In recent years, biotechnologically derived peptide and protein-based drugs have developed into mainstream therapeutic agents. Peptide and protein drugs now constitute a substantial portion of the compounds under preclinical and clinical development in the global pharmaceutical industry. Pharmacokin
Biotechnological aspects of antibody production in E. coli
✍ Scribed by A. Plückthun
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 652 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0138-4988
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Due to the increasing world population, supply of steroids is dwindling. New sources of steroids is dwindling. New Sources of steroids may be found and the existing steroids and sterols may be better utilized. The role of biotechnology in the production and efficient utilization of ster
Fed-batch fermentation for production of a single-chain Fv antibody fragment (scFv) expressed as a recombinant periplastic protein from Escherichia coli was investigated. A high cell density of 50 g dry cell weight per liter was routinely achieved in a 14-L vessel by controlled exponential feeding o